← back to search

Pavel Strop

Bristol-Myers Squibb (Germany) · DE
Area of research
Radiology, Nuclear Medicine and Imaging · Hematology
Research interest
Research interests include Monoclonal and Polyclonal Antibodies Research, Multiple Myeloma Research and Treatments, HER2/EGFR in Cancer Research, and Synthesis and Biological Evaluation.
h-index
43
citations
6,914
works
142
NIH funding
primary concept
email

Recent publications

Targeted Delivery of TLR7 Agonists to the Tumor Microenvironment Enhances Tumor Immunity via Activation of Tumor-Resident Myeloid Cells.
2025cited by 4position: contributordoi
Residue-Level Characterization of Antibody Binding Epitopes Using Carbene Chemical Footprinting.
2023cited by 4position: contributordoi
Supplementary Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
2023cited by 0position: contributordoi
Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
2023cited by 0position: contributordoi
Supplementary Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
2023cited by 0position: contributordoi
Data from Preclinical Characterization of Relatlimab, a Human LAG-3–Blocking Antibody, Alone or in Combination with Nivolumab
2023cited by 0position: contributordoi
Preclinical Characterization of Relatlimab, a Human LAG-3-Blocking Antibody, Alone or in Combination with Nivolumab.
2022cited by 62position: contributordoi
High-Throughput Surface Plasmon Resonance Biosensors for Identifying Diverse Therapeutic Monoclonal Antibodies.
2021cited by 11position: contributordoi
Automated and Faster Affinity Capture Method for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
2021cited by 8position: contributordoi
Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.
2020cited by 25position: contributordoi
Integrated Approach for Characterizing Bispecific Antibody/Antigens Complexes and Mapping Binding Epitopes with SEC/MALS, Native Mass Spectrometry, and Protein Footprinting.
2020cited by 14position: contributordoi
High-Throughput Platform to Identify Antibody Conjugation Sites from Antibody-Drug Conjugate Libraries.
2020cited by 4position: contributordoi
Preclinical Efficacy and Safety Comparison of CD3 Bispecific and ADC Modalities Targeting BCMA for the Treatment of Multiple Myeloma
Molecular Cancer Therapeutics 2019cited by 47position: middledoi
The role of MscL amphipathic N terminus indicates a blueprint for bilayer-mediated gating of mechanosensitive channels
Nature Communications 2016cited by 114position: middledoi
Fabs Enable Single Particle cryoEM Studies of Small Proteins
Structure 2012cited by 187position: middledoi
A method for integrative structure determination of protein-protein complexes
Bioinformatics 2012cited by 84position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 12 papers (2020–2025)Jason M. Hogan · American Chemical Society6 papers (2022–2023)Julie A. Zorn · Bristol-Myers Squibb (United States)5 papers (2022–2023)Gregory Rak · Kallyope (United States)5 papers (2022–2023)Kent Thudium · Bristol-Myers Squibb Research5 papers (2022–2023) · 5 papers (2022–2023)Xi-Tao Wang · Bristol-Myers Squibb (United States)5 papers (2022–2023)Roderick Todd Bunch · Bristol-Myers Squibb (United States)5 papers (2022–2023)Mark Selby · Bristol-Myers Squibb (Germany)5 papers (2022–2023)Alan J. Korman · Bristol-Myers Squibb (Germany)5 papers (2022–2023)Srikanth Kotapati · University of Minnesota4 papers (2020–2025)Sayumi Yamazoe · Bristol-Myers Squibb (Germany)3 papers (2020–2025)Agustin Avila-Sakar · Lawrence Berkeley National Laboratory2 papers (2012–2012)Maofu Liao · Southern University of Science and Technology2 papers (2012–2012)Yifan Cheng · Howard Hughes Medical Institute2 papers (2012–2012) · 1 papers (2016–2016) · 1 papers (2012–2012)Kristin A. Krukenberg · Harvard University1 papers (2012–2012)Charles D. Cox · UNSW Sydney1 papers (2016–2016)Charles H. Greenberg · University of California, San Francisco1 papers (2012–2012)